Work

Phase 1 study results with PRAME-directed T-cell receptor (TCR) T-cell therapies in synovial sarcoma.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.11516

Authors: Dejka M. Araujo, Manik Chatterjee, Diwakar Davar, Leonel Fernando Hernandez-Aya, Ran Reshef, Dmitry Pankov, Delfi Krishna, Friedrich Vollmer, Ana Maia, Regina Mendrzyk, Cedrik Michael Britten, Martin Wermke

Institutions: The University of Texas MD Anderson Cancer Center, Universitätsklinikum Würzburg, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, University of Miami, Columbia University Irving Medical Center, Immatics Biotechnologies (Germany), Nationales Centrum für Tumorerkrankungen Dresden, Technische Universität Dresden

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162569800

Cites:

Cited by: 2

Related to: